Probiotics-supplemented feeding in extremely low-birth-weight infants

M Al-Hosni1, M Duenas, M Hawk

  • 1Department of Pediatrics, Saint Louis University School of Medicine, St Louis, MO, USA. alhosnim@slu.edu

Insights

Probiotic-supplemented feeding in extremely low-birth-weight (ELBW) infants improved growth velocity but did not reduce the percentage of infants with growth delay. No adverse events were reported in this randomized controlled trial.

Area of Science:

  • Neonatal nutrition and growth
  • Probiotic supplementation in infants
  • Extremely low-birth-weight (ELBW) infant care

Background:

  • Extremely low-birth-weight (ELBW) infants are at high risk for growth delay and feeding intolerance.
  • Probiotics are being investigated for their potential to improve gut health and growth in vulnerable infant populations.
  • Previous studies have shown mixed results regarding the efficacy of probiotics in ELBW infants.

Purpose of the Study:

  • To determine if probiotic-supplemented enteral feeding improves growth in ELBW infants by reducing the percentage of infants below the 10th percentile weight at 34 weeks postmenstrual age (PMA).
  • To evaluate the impact of probiotics on feeding tolerance, including daily feeding volumes.
  • To assess the effect of probiotics on the duration of antimicrobial treatment within the first 28 days.

Main Methods:

  • A multicenter, randomized, double-blinded, controlled clinical study.
  • Participants received either Lactobacillus rhamnosus GG and Bifidobacterium infantis (probiotic-supplementation group) or unsupplemented enteral feedings (control group).
  • Infant weights, feeding volumes, and antimicrobial treatment days were monitored daily for 28 days; weights were also recorded at 34 weeks PMA.

Main Results:

  • No significant difference was observed in the percentage of infants with weight below the 10th percentile at 34 weeks PMA between the probiotic (58%) and control (60%) groups (P=0.83).
  • The probiotic group showed a higher calculated growth velocity (14.9 g/day) compared to the control group (12.6 g/day) (P=0.05).
  • Feeding volumes and incidences of necrotizing enterocolitis (NEC) and mortality were similar between the groups.

Conclusions:

  • Probiotic supplementation enhanced growth velocity in ELBW infants but did not improve the primary outcome of reducing the percentage of infants with growth delay at 34 weeks PMA.
  • The study found no significant differences in feeding tolerance or NEC between the groups.
  • No probiotic-related adverse events were reported, suggesting a favorable safety profile.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...